Activation of CPP32-like proteases is not sufficient to trigger apoptosis: Inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity

Journal of Experimental Medicine

Volumn 186, Issue 7, 1997, Pages 1107-1117

  Wright, Susan C ^a   Schellenberger, Ute ^a   Wang, Hong ^a   Kinder, David H ^b   Talhouk, Jamil W ^a   Larrick, James W ^a  

^a Palo Alto Institute of Molecular Medicine   (United States)

^b OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DNA FRAGMENT; ENZYME INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN KINASE INHIBITOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

APOPTOSIS; ARTICLE; CELL DEATH; DNA DAMAGE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 1; CASPASE 3; CASPASES; CELL MEMBRANE PERMEABILITY; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOMA; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 0030777366     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.7.1107     Document Type: Article

References (48)

1. Wertz, I.E., and M.R. Hanley. 1996. Diverse molecular provocation of programmed cell death. TIBS (Trends Biochem. Sci.). 21:359-364.
2. McConkey, D.J., and S. Orrenius. 1994. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:370-375.
3. Patel, T., G.J. Gores, and S.H. Kaufman. 1996. The role of proteases during apoptosis. FASEB J. 10:587-597.
4. Martin, S.J., and D.R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349-352.
5. Martins, L.M., and W.C. Earnshaw. 1997. Apoptosis: alive and kicking in 1997. Trends Cell Biol. 7:111-114.
6. Henkart, P.A. 1996. ICE family proteases: Mediators of all apoptotic death? Immunity. 4:195-201.
7. Ashkenas, J., and Z. Werb. 1996. Proteolysis and the biochemistry of life-or-death decisions. J. Exp. Med. 183:1947-1951.
8. Casciola-Rosen, L., D.W. Nicholson, T. Chong, K.R. Rowan, N.A. Thornberry, D.K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957-1964.
9. Nicholson, D.W., A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for apoptosis. Nature (Lond.). 376:37-43.
10. Wright, S.C., Q.S. Wei, J. Zhong, H. Zheng, D.H. Kinder, and J.W. Larrick. 1994. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J. Exp. Med. 180:2113-2123.
11. Obeid, L.M., C.M. Linardic, L.A. Karolak, and Y.A. Hannun. 1993. Programmed cell death induced by ceramide. Science (Wash. DC). 259:1769-1771.
12. Dressler, K.A., S. Mathias, and R.N. Kolesnick. 1992. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science (Wash. DC). 255:1715-1718.
13. Wright, S.C., H. Zheng, and J. Zhong. 1996. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24-kD apoptotic protease (AP24). FASEB J. 10:325-332.
14. Agarwal, S., B.-E. Drysdale, and H.S. Shin. 1988. Tumor necrosis factor-α mediated cytotoxicity involves ADP-ribosylation. J. Immunol. 140:4187-4192.
15. Nosseri, C., S. Coppola, and L. Ghibelli. 1994. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp. Cell Res. 212:367-373.
16. Schulze-Osthoff, K., P.H. Krammer, and W. Droge. 1994. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO (Eur. Mol. Biol. Organ.) J. 13:4587-4596.
17. Wright, S.C., P. Kumar, A.W. Tam, N. Shen, M. Varma, and J.W. Larrick. 1992. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J. Cell. Biochem. 48:344-355.
18. Wright, S.C., Q.S. Wei, D.H. Kinder, and J.W. Larrick. 1996. Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation. J. Exp. Med. 183:463-471.
19. Wright, S.C., H. Zheng, J. Zhong, F.M. Torti, andJ.W. Larrick. 1993. Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF resistant U937 variants. J. Cell. Biochem. 53:222-233.
20. 19a. Wright, S.C., U. Schellenberger, L. Ji, H. Wang, and J.W. Larrick. 1997. Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis. FASEB J. 11:843-849.
21. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16:998-1006.
22. Datta, R., H. Kojima, D. Banach, N.J. Bump, R.V. Talanian, E.S. Alnemri, R.R. Weichselbaum, W.W. Wong, and D.W. Kufe. 1997. Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272:1965-1969.
23. L. J. Biol. Chem. 271:17601-17604.
24. Kinder, D.H., and J.A. Katzenellenbogen. 1985. Acrylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase. J. Med. Chem. 28:1917-1925.
25. Kinder, D.H., C.A. Elstad, G.G. Meadows, and M.M. Ames. 1992. Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivo. Invasion Metastasis. 12:309-405.
26. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:4314-4320.
27. 2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926. Biochem. Biophys. Res. Commun. 181:423-429.
28. Dubrez, L., I. Savoy, A. Hamman, and E. Solary. 1996. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15:5504-5512.
29. Lin, Y.-Z., S.Y. Yao, R.A. Veach, T.R. Torgerson, and J. Hawiger. 1995. Inhibition of nuclear translocation of transcription factor NF-kB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 279:14255-14258.
30. Williams, M.S., and P.A. Henkart. 1994. Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 153:4247-4255.
31. Singer, I.I., S. Scot, J. Chin, E.K. Bayne, G. Limjuco, J. Weidner, D.K. Miller, K. Chapman, and M.J. Kostura. 1995. The interleukin-1β-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182:1447-1459.
32. Haimovitz-Friedman, A., N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, I. Vlodavsky, and Z. Fuks. 1994. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54:2591-2597.
33. Shi, L., R.P. Kraut, R. Aebersold, and A.H. Greenberg. 1992. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175:553-566.
34. Miura, M., H. Zhu, R. Rotello, E.A. Hartwieg, and Y. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1β converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:653-663.
35. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
36. Liu, X., H. Zou, C. Slaughter, and X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89: 175-184.
37. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Prof. Natl. Acad. Sci. USA. 94:3759-3764.
38. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.-L. Vayssiere, P.X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181: 1661-1672.
39. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Wash. DC). 275:1129-1132.
40. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC). 275:1132-1136.
41. Miossec, C., V. Dutilleul, F. Fassy, and A. Diu-Hercend. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272: 13459-13462.
42. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science (Wash. DC). 267:1456-1462.
43. Nicholson, D.W. 1996. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotech. 14:297-301.
44. Johnson, E.M., L.J. Greenlund, and C.Y. Hsu. 1995. Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury. J. Neurotrauma. 5:843-852.
45. Narula, J., N. Haider, R. Virmani, T.G. DiSalvo, F.D. Kolodgie, R.J. Hajjar, U. Schmidt, M.J. Semigran, G.W. Dec, and B.-A. Khaw. 1996. Apoptosis in myocytes in endstage heart failure. N. Engl. J. Med. 335:1182-1189.
46. Olivetti, G., R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J.A. Nitahara, E. Quaii, C. Di Loreto, C.A. Beltrami, S. Krajewski, et al. 1997. Apoptosis in the failing human heart. N. Engl. J. Med. 336:1131-1141.
47. Mallat, Z., A. Tedgui, F. Fontaliran, R. Frank, M. Durigon, and G. Fontaine. 1996. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N. Engl. J. Med. 17: 1190-1199.
48. Hara, H., R.M. Friedlander, V. Gagliardini, C. Ayata, K. Fink, Z. Huang, M. Shimizu-Sasamata, J. Yuan, and M.A. Moskowitz. 1997. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc: Natl. Acad. Sci. USA. 94:2007-2012.